Enzymaster
酶赛生物
Enzymaster
Biotech/Healthcare
A provider of protein engineering and directed biocatalysis solutions.
Latest round: Series C Extension (2022)
Source: ChinaBulls — chinabulls.com
Last updated 2022-01-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.